Top Markets
#1 DogBull DogBull +104.72%
#2 ADO Protocol ADO Protocol +63.10%
#3 Siacoin Siacoin +51.97%
#4 MarsCoin MarsCoin +34.95%
#5 Useless Coin Useless Coin +32.42%
#6 UnifAI Network UnifAI Network +27.31%
#7 Ontology Gas Ontology Gas +24.33%
#8 Glidr Glidr +19.86%
#9 Falcon Finance Falcon Finance +17.27%
#10 Apertum Apertum +14.71%
Coin of the day
DogBull DogBull
設定
言語
日本
通貨
USD
テーマ
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
株式のランク #15974
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
株価
$15.42
時価総額
$320.83M
変化（1日）
-1.52%
変化（1年）
40.67%
国
IT
取引 Newron Pharmaceuticals S.p.A. (NP5)

カテゴリー

Healthcare
Newron Pharmaceuticals S.p.A.（NP5）の配当履歴
Newron Pharmaceuticals S.p.A.（証券コード：NP5）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのNewron Pharmaceuticals S.p.A.（NP5）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH